Ignite Creation Date:
2024-05-06 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03547999
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2018-05-23
Brief Title:
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
Sponsor:
Patrick Boland
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HCRN GI16-288
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Patrick Boland
Lead Sponsor Class:
OTHER
Responsible Party:
Patrick Boland
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bavarian Nordic | INDUSTRY |
| Hoosier Cancer Research Network | OTHER |
| Bristol-Myers Squibb | INDUSTRY |